))
AI’s and Spatial Biology’s Potential for Curing Cancer, w/ Nucleai CEO Avi Veidman
Manage episode 427147635 series 3503527
Contenu fourni par Jeff Wilser. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Jeff Wilser ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
For over 20 years, Avi Veidman served in the Israeli intelligence forces, and he used AI to to map the world. In the military he used AI for national defense, and he learned its power.
He then realized that just as AI could map a battlefield, it could map cancer cells in biopsies and pathology slides.
Enter Nucleai, his company that’s using AI to improve the science of “spatial biology,” which can ultimately unlock new treatments and cures…with cancer on their radar.
Avi and I get into how this all works, the staggering potential, and the real-world challenges that need to be overcome.
Nucleai
Merck’s $14 million investment in Nucleai:
60 episodes
Partager
